[Transfer factors in medical therapy]

Med Clin (Barc). 2011 Sep 10;137(6):273-7. doi: 10.1016/j.medcli.2010.05.002. Epub 2010 Jun 18.
[Article in Spanish]

Abstract

Transfer factor (TF) consists of messenger peptides produced by activated T lymphocytes as part of cellular immunity, and it acts in virgin lymphocytes through TF inducers, suppressors and specific antigens. TF is not immunogenic because it is not species-specific, since it contains a consensus sequence of amino acids LLYAQDL/VEDN. TF extracted from leukocytes can transfer immunity from a human to another species. TF extracts are complex, containing more than 200 molecules with molecular weights ranging from 1 to 20 kDa. The antigen specific transfer factors (STF) have molecular weights between 3,5 and 5 kDa. TF is easy to prepare and well tolerated. It does not contain HL-A antigens against potential receptors and it can used as adjuvant therapy in several diseases.

Publication types

  • English Abstract

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Colostrum / chemistry
  • Consensus Sequence
  • Double-Blind Method
  • Humans
  • Lymphocyte Activation
  • Multiple Sclerosis / drug therapy
  • Neoplasms / drug therapy
  • T-Lymphocytes / metabolism
  • Transfer Factor / chemistry
  • Transfer Factor / isolation & purification
  • Transfer Factor / physiology
  • Transfer Factor / therapeutic use*
  • Treatment Outcome
  • Tuberculosis / drug therapy

Substances

  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Transfer Factor